Predicting mortality in geriatric patients with peptic ulcer bleeding: a retrospective comparative study of four

Omerul Faruk Aydin1, Ali Cankut Tatlıparmak2

  • 1Department of Emergency Medicine, İstanbul Yeni Yüzyıl University, İstanbul, Turkey.

Peerj
|March 21, 2025
PubMed

Insights

The AIMS65 score is the most accurate tool for predicting mortality in elderly patients with peptic ulcer bleeding (PUB). This finding helps improve risk stratification for high-risk geriatric patients with PUB.

Area of Science:

  • Gastroenterology
  • Geriatric Medicine
  • Clinical Epidemiology

Background:

  • Peptic ulcer bleeding (PUB) poses a significant mortality risk, particularly in older adults.
  • Several scoring systems, including AIMS65, Glasgow Blatchford Score (GBS), T-score, and Age, Blood tests, and Comorbidities (ABC) score, are used for risk stratification in PUB.
  • The comparative effectiveness of these tools in the geriatric population requires further investigation.

Purpose of the Study:

  • To compare the predictive performance of AIMS65, GBS, T-score, and ABC score for in-hospital mortality in geriatric patients with PUB.
  • To identify the most accurate scoring system for risk stratification in this vulnerable patient group.

Main Methods:

  • Retrospective cohort study of patients aged 65 and older diagnosed with PUB.
  • Inclusion criteria: diagnosis of PUB between January 1, 2019, and January 1, 2024.
  • Data collected: demographics, clinical presentation, lab results, comorbidities; calculation of AIMS65, GBS, T-score, and ABC score; primary outcome: in-hospital mortality.

Main Results:

  • A total of 315 geriatric patients with PUB were analyzed, with an in-hospital mortality rate of 7.9%.
  • AIMS65 demonstrated the highest predictive accuracy (AUROC: 0.829), followed by the ABC score (AUROC: 0.775).
  • GBS (AUROC: 0.694) and T-score (AUROC: 0.526) showed lower predictive performance; AIMS65 significantly outperformed GBS (p=0.0214).

Conclusions:

  • AIMS65 and ABC scores are superior to GBS and T-score in predicting in-hospital mortality for geriatric patients with PUB.
  • These findings support the use of AIMS65 and ABC scores for improved risk stratification and clinical decision-making in elderly PUB patients.
Abstract

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
56
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
111
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
186
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
73
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
186
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
329